The community for India's most competitive biopharmaceutical companies.

Over the past few years, the IndiaBio Hotbed has made a name for itself in increasingly competitive biopharmaceutical niches. Specifically, India has become a leader in vaccine development and bioinformatics among others. India is also a global leader in contract research and development and manufacturing. IndiaBio is emerging as one of the strongest biopharmaceutical markets in Asia and is expected to continue growing and developing.


Hotbed News
Gilead Sciences, Inc. (GILD) Says Indian Firms May Sell Generics of Hep C Drug Sovaldi Wednesday, September 17, 2014
Hetero Enters License Agreement With Gilead Sciences, Inc. (GILD), U.S.A. To Produce Generic Sofosbuvir For Treatment Of Chronic Hepatitis C Wednesday, September 17, 2014
Glenmark Pharmaceuticals's TRPA1 Antagonist 'GRC 17536' Shows Positive Data In A Proof Of Concept Study Wednesday, September 17, 2014
Indian Media Accuse Biggest Medtechs Medtronic, Inc. (MDT), Abbott Laboratories (ABT), Johnson & Johnson (JNJ) Of Price-Hikes, Bribery Wednesday, September 17, 2014
Johnson & Johnson (JNJ)'s Biggest Plant Coming Up In Telangana Wednesday, September 17, 2014
Lupin Ltd. (LUPN.BO) May Sign $1.5 Billion Deal With Merck Serono; Lupin Stock Hits A New High Tuesday, September 16, 2014
India’s Dept Of Biotech Plans Financial Help For The Biotech Industry Tuesday, September 16, 2014
FDA's Surprise Visit To Sun Pharmaceutical Industries Ltd (SUNPHARMA.NS)'s Pressures Stock Monday, September 15, 2014
Hospira, Inc. Plans Pharma University In Vizag Friday, September 12, 2014
Pfizer (PFE) Forced To Lock Workers Out Of Plant In India Thursday, September 11, 2014